Dec. 13, 2005 -- The US Food and Drug Administration (FDA) has approved orphan drug status for mecasermin rinfabate [rDNA origin] subcutaneous injection in the treatment of children with severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results